• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CV 6209是豚鼠腹腔常驻巨噬细胞上血小板活化因子受体的非竞争性拮抗剂。

CV 6209 is a non-competitive antagonist of platelet-activating factor receptors on guinea-pig resident peritoneal macrophages.

作者信息

Stewart A G

机构信息

Department of Physiology, University of Melbourne, Parkville, Victoria, Australia.

出版信息

Clin Exp Pharmacol Physiol. 1989 Nov;16(11):813-20. doi: 10.1111/j.1440-1681.1989.tb01520.x.

DOI:10.1111/j.1440-1681.1989.tb01520.x
PMID:2558827
Abstract
  1. The characteristics of antagonism of platelet-activating factor (Paf) receptors by the phospholipid Paf analogue, CV 6209, were studied in rabbit platelets and polymorphonuclear leucocytes (PMN) and in guinea-pig macrophages. 2. Paf-induced aggregation of PMN or platelets was antagonized in a competitive and specific manner by CV 6209 with no detectable difference between the pA2 values (approximately 9.5). 3. The specificity of CV 6209 (1-100 nmol/L) for Paf receptors in platelets and PMN was indicated by a lack of effect on A23187 (10 mumols/L) or fMLP (1 mumol/L) induced aggregation, respectively. 4. CV 6209 (1-100 nmol/L) was also a potent antagonist of Paf-induced prostacyclin (PGI2) generation by guinea-pig peritoneal macrophages. However, CV 6209 caused significant depression of the maximum response to Paf and a non-parallel shift in the concentration-response curve indicating a non-competitive type antagonism. 5. PGI2 generation induced by the ionophore A23187 was unaffected by CV 6209 (up to 100 nmol/L) whereas basal PGI2 production by macrophages was reduced by lower concentrations (10-100 nmol/L). These observations are not consistent with a direct effect of CV 6209 on the enzymes involved in PGI2 synthesis but do suggest that endogenous Paf regulates basal PGI2 generation. 6. The non-competitive antagonism of guinea-pig macrophage Paf receptors gives further support to the contention that these receptors are distinct from those mediating aggregation of platelets and PMN.
摘要
  1. 在兔血小板、多形核白细胞(PMN)和豚鼠巨噬细胞中研究了磷脂Paf类似物CV 6209对血小板活化因子(Paf)受体的拮抗特性。2. CV 6209以竞争性和特异性方式拮抗Paf诱导的PMN或血小板聚集,pA2值(约9.5)之间无明显差异。3. CV 6209(1 - 100 nmol/L)对血小板和PMN中Paf受体的特异性表现为分别对A23187(10 μmol/L)或fMLP(1 μmol/L)诱导的聚集无影响。4. CV 6209(1 - 100 nmol/L)也是豚鼠腹膜巨噬细胞中Paf诱导的前列环素(PGI2)生成的有效拮抗剂。然而,CV 6209导致对Paf的最大反应显著降低,且浓度 - 反应曲线发生非平行位移,表明是非竞争性拮抗类型。5. 离子载体A23187诱导的PGI2生成不受CV 6209(高达100 nmol/L)影响,而巨噬细胞的基础PGI2产生在较低浓度(10 - 100 nmol/L)时减少。这些观察结果与CV 6209对参与PGI2合成的酶的直接作用不一致,但确实表明内源性Paf调节基础PGI2生成。6. 豚鼠巨噬细胞Paf受体的非竞争性拮抗进一步支持了这些受体与介导血小板和PMN聚集的受体不同的观点。

相似文献

1
CV 6209 is a non-competitive antagonist of platelet-activating factor receptors on guinea-pig resident peritoneal macrophages.CV 6209是豚鼠腹腔常驻巨噬细胞上血小板活化因子受体的非竞争性拮抗剂。
Clin Exp Pharmacol Physiol. 1989 Nov;16(11):813-20. doi: 10.1111/j.1440-1681.1989.tb01520.x.
2
Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages.血小板、多形核白细胞和巨噬细胞上血小板活化因子受体的特性研究。
Br J Pharmacol. 1988 Aug;94(4):1225-33. doi: 10.1111/j.1476-5381.1988.tb11642.x.
3
Intracellular platelet-activating factor regulates eicosanoid generation in guinea-pig resident peritoneal macrophages.细胞内血小板活化因子调节豚鼠腹膜常驻巨噬细胞中类花生酸的生成。
Br J Pharmacol. 1989 Sep;98(1):141-8. doi: 10.1111/j.1476-5381.1989.tb16874.x.
4
Equine peritoneal macrophage production of thromboxane and prostacyclin in response to platelet activating factor and its receptor antagonist SRI 63-441.马腹膜巨噬细胞对血小板活化因子及其受体拮抗剂SRI 63 - 441的反应中血栓素和前列环素的产生
Circ Shock. 1989 Jun;28(2):149-58.
5
Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.使用[3H]阿帕泛(一种选择性竞争性血小板活化因子拮抗剂)对豚鼠腹腔巨噬细胞上血小板活化因子受体进行药理学特性研究:阿帕泛在功能研究中的非竞争性行为与解离动力学缓慢有关的证据。
Mol Pharmacol. 1993 Feb;43(2):302-12.
6
The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes.血小板活化因子受体拮抗剂RP 59227可阻断介导豚鼠巨噬细胞和人多形核白细胞中活性氧释放的血小板活化因子受体。
J Pharmacol Exp Ther. 1991 Aug;258(2):567-75.
7
1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity.1-O-十六烷基-2-乙酰基-sn-甘油-3-磷酸(N,N,N-三甲基)己醇胺:一种具有部分激动剂活性的血小板活化因子类似物。
Br J Pharmacol. 1991 Sep;104(1):171-7. doi: 10.1111/j.1476-5381.1991.tb12403.x.
8
Biological response of guinea pig peritoneal macrophages to platelet-activating factor.豚鼠腹膜巨噬细胞对血小板活化因子的生物学反应。
Lipids. 1991 Dec;26(12):1193-9. doi: 10.1007/BF02536530.
9
Structure-activity relationships for platelet-activating factor (PAF) and analogues reveal differences between PAF receptors on platelets and macrophages.血小板活化因子(PAF)及其类似物的构效关系揭示了血小板和巨噬细胞上PAF受体之间的差异。
J Lipid Mediat. 1991 Nov;4(3):299-308.
10
Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the platelet.CV-3988对[3H] -血小板活化因子(PAF)与血小板结合的抑制作用。
Biochem Pharmacol. 1985 May 1;34(9):1491-5. doi: 10.1016/0006-2952(85)90689-6.

引用本文的文献

1
PAF. A review of its effects, antagonists and possible future clinical implications (Part II).血小板活化因子。其作用、拮抗剂及未来可能的临床意义综述(第二部分)
Drugs. 1991 Aug;42(2):174-204. doi: 10.2165/00003495-199142020-00002.